Key statistics
As of last trade, Armata Pharmaceuticals Inc (TG1N:DEU) traded at 2.06, 15.73% above the 52 week low of 1.78 set on Nov 28, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.95 |
---|---|
High | 2.06 |
Low | 1.95 |
Bid | 2.04 |
Offer | 2.18 |
Previous close | 1.93 |
Average volume | 0.00 |
---|---|
Shares outstanding | 36.18m |
Free float | 10.77m |
P/E (TTM) | -- |
Market cap | 86.84m USD |
EPS (TTM) | -1.95 USD |
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Press releases
- Armata Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
- Armata Pharmaceuticals Announces Presentation at the 2024 Military Health System Research Symposium
- Armata Pharmaceuticals Announces Appointment of Life Sciences Accounting and Finance Veteran David House as SVP of Finance and Principal Financial Officer
- Armata Pharmaceuticals Announces Second Quarter 2024 Results and Provides Corporate Update
- Armata Pharmaceuticals Receives $5.25 Million of Additional Non-Dilutive Grant Funding from the U.S. Department of Defense to Support Ongoing diSArm Clinical Trial of AP-SA02
- Armata Pharmaceuticals Announces Completion of Enrollment of Phase 2 Tailwind Study of Inhaled AP-PA02 in Non-Cystic Fibrosis Bronchiectasis Subjects with Chronic Pulmonary Pseudomonas aeruginosa Infection
More ▼